Today: 25 January 2026
Subscribe

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

Rivian Stock Today (RIVN): Q3 2025 Earnings, Seat Belt Recall, VW Joint Venture and New Price Targets — December 4, 2025 Update

Rivian Stock Today (RIVN): Q3 2025 Earnings, Seat Belt Recall, VW Joint Venture and New Price Targets — December 4, 2025 Update

Rivian Automotive (NASDAQ: RIVN) trades near 52‑week highs after a strong Q3 2025, even as a major recall, mixed Wall Street targets and a high‑stakes Volkswagen software deal keep the stock volatile. Here’s a full news and forecast rundown as of December 4, 2025. Rivian’s Setup on 4 December 2025: Rallying Into Uncertainty Rivian Automotive, Inc. (NASDAQ: RIVN) is finishing…
4 December 2025
····
MongoDB Stock (MDB) After Blowout Q3 Earnings: Analyst Upgrades, Valuation Risks and 2026–2027 Forecasts – December 4, 2025

MongoDB Stock (MDB) After Blowout Q3 Earnings: Analyst Upgrades, Valuation Risks and 2026–2027 Forecasts – December 4, 2025

MongoDB, Inc. (NASDAQ: MDB) has become one of the most closely watched software stocks this week after a powerful post‑earnings rally, a wave of Wall Street price-target hikes, and fresh valuation debates. As of the close on December 4, 2025, MongoDB stock is trading just under $400 per share, up roughly 70% year-to-date, near the top of its 52‑week range…
4 December 2025
····
NuScale Power (SMR) Stock Forecast: December 2025 Rally Tests Nuclear‑AI Hype Against Dilution Risk

NuScale Power (SMR) Stock Forecast: December 2025 Rally Tests Nuclear‑AI Hype Against Dilution Risk

Published: December 4, 2025 NuScale Power Corporation (NYSE: SMR) is back in the spotlight. After a brutal November sell‑off that sliced the share price in half from its mid‑October peak, the small modular reactor (SMR) developer is rebounding sharply as nuclear power, artificial intelligence (AI) and U.S. energy policy collide. By early afternoon on December 4, 2025, NuScale shares were…
4 December 2025
····
Ulta Beauty Q3 2025 Earnings: Double‑Digit Sales Growth and Higher Guidance Show Beauty Demand Is Still Booming

Ulta Beauty Q3 2025 Earnings: Double‑Digit Sales Growth and Higher Guidance Show Beauty Demand Is Still Booming

Ulta Beauty’s third‑quarter 2025 earnings report delivered exactly what investors wanted to see: faster growth, a clear beat on Wall Street forecasts, and a meaningfully higher full‑year outlook backed by surprisingly resilient demand for makeup, skincare and fragrance. On December 4, the specialty beauty retailer reported fiscal Q3 2025 net sales of about $2.86 billion, up 12.9% year on year,…
4 December 2025
··
DocuSign Q3 2026 Earnings Beat Forecasts as AI Strategy Scales, But DOCU Stock Slips on Soft Q4 Outlook

DocuSign Q3 2026 Earnings Beat Forecasts as AI Strategy Scales, But DOCU Stock Slips on Soft Q4 Outlook

Updated: December 4, 2025 DocuSign, Inc. (NASDAQ: DOCU) reported fiscal third‑quarter 2026 results for the period ended October 31, 2025, posting stronger‑than‑expected revenue and earnings and nudging its full‑year guidance higher. However, the initial market reaction was muted to negative: the stock traded 2–4% lower at points in extended and afternoon trading, as investors zeroed in on cautious fourth‑quarter guidance…
4 December 2025
···
Rubrik Stock Rockets After Q3 2026 Earnings Beat: 48% Revenue Surge, First Profit and Raised 2026 Outlook

Rubrik Stock Rockets After Q3 2026 Earnings Beat: 48% Revenue Surge, First Profit and Raised 2026 Outlook

December 4, 2025 – New York / Palo Alto Rubrik Inc. (NYSE: RBRK) just delivered the kind of quarter that can change a growth stock’s story almost overnight. The cybersecurity and “Security & AI Operations” company smashed Wall Street expectations for its fiscal third quarter 2026, posting a surprise profit, accelerating revenue growth and sharply narrowing its loss outlook for…
4 December 2025
····
HPE Stock Falls as Weak 2026 Revenue Forecast Overshadows Q4 2025 Earnings Beat

HPE Stock Falls as Weak 2026 Revenue Forecast Overshadows Q4 2025 Earnings Beat

Hewlett Packard Enterprise (NYSE: HPE) reported fiscal fourth‑quarter 2025 results on Thursday, December 4, that topped profit expectations but missed Wall Street’s revenue targets and came with a softer‑than‑expected sales outlook for early fiscal 2026. That combination sent the stock down roughly 4–5% in after‑hours trading, even though it has gained about 6% over the past year. Reuters At the…
4 December 2025
····
Capital One (COF) Stock on December 4, 2025: Discover Deal, FDIC Lawsuit and Q3 Earnings Rebound

Capital One (COF) Stock on December 4, 2025: Discover Deal, FDIC Lawsuit and Q3 Earnings Rebound

Capital One Financial Corporation (NYSE: COF) is finishing 2025 looking very different from the bank it was just two years ago. After closing its $35.3 billion all‑stock acquisition of Discover Financial Services in May, the company is now the largest U.S. credit card issuer and a major player in payments infrastructure. Capital One Investor At the same time, Capital One…
4 December 2025
····
Carvana (CVNA) Stock Outlook for December 4, 2025: UBS Strong‑Buy Call, S&P 500 Buzz and a Fresh Bear Case

Carvana (CVNA) Stock Outlook for December 4, 2025: UBS Strong‑Buy Call, S&P 500 Buzz and a Fresh Bear Case

As of December 4, 2025, Carvana Co. (NYSE: CVNA) is one of the market’s most hotly debated stocks – with Wall Street upgrades, franchise expansion and S&P 500 chatter on one side, and sharp new bear theses and algorithmic downside forecasts on the other. Carvana stock today: price, performance and volatility Carvana shares closed around $398–$399 on December 4, 2025,…
4 December 2025
···
Poundland to Shut Prestatyn Retail Park Store as December 2025 Closures Hit UK High Streets

Poundland to Shut Prestatyn Retail Park Store as December 2025 Closures Hit UK High Streets

Published 4 December 2025 Poundland has confirmed that its store at Parc Prestatyn retail park in Denbighshire will close, in a decision the retailer says follows a failure to agree new lease terms with the site’s landlord. Facebook The move comes as the discount chain presses ahead with a court‑sanctioned restructuring plan after being sold for just £1 earlier this…
4 December 2025
·
Home Depot (HD) Stock on December 4, 2025: Dividend Deadline, Instacart Deal, ICE Raids and a Make‑or‑Break Investor Day Ahead

Home Depot (HD) Stock on December 4, 2025: Dividend Deadline, Instacart Deal, ICE Raids and a Make‑or‑Break Investor Day Ahead

Ticker: NYSE: HD | Sector: Home Improvement RetailPublished: December 4, 2025 Home Depot Stock Today: Price, Performance and Context As of the close on December 4, 2025, shares of The Home Depot, Inc. (HD) finished around $351 per share, down roughly 1.9% on the day and trading well below their 52‑week high near $436. StockAnalysis Year to date, HD is…
4 December 2025
···
Polyrizon (PLRZ) Stock Explodes on Naloxone Hydrogel Breakthrough and PL‑14 Upscaling – What Investors Should Know Now

Polyrizon (PLRZ) Stock Explodes on Naloxone Hydrogel Breakthrough and PL‑14 Upscaling – What Investors Should Know Now

Polyrizon Ltd. (NASDAQ: PLRZ) has gone from obscure micro‑cap to headline‑grabbing biotech in just two trading days. On December 4, 2025, the stock was changing hands in the mid‑teens, more than doubling from the prior close of $7.09, with intraday swings between roughly $12.5 and $18.2 and volume near 26 million shares – over 20× its recent average. MarketBeat Behind…
4 December 2025
····
1 … 725 726 727 728 729 … 812

Stock Market Today

  • BillionToOne (BLLN) Shares Pull Back Amid Growth Prospects and Valuation Debate
    January 25, 2026, 7:59 AM EST. BillionToOne (BLLN) shares slipped 3.3% in one day, trading near $87.57, down 1.93% year-to-date. The diagnostics company shows 22.88% annual revenue growth but trades at a 45.31% discount to a $135.29 fair value estimate. Growth in noninvasive prenatal testing and a key Johnson & Johnson diagnostic partnership support optimism. However, increased competition in prenatal testing and potential reimbursement cuts pose risks. Investors are weighing whether the sell-off highlights a buying opportunity or reflects market caution about future growth. The firm's valuation rests on assumptions of revenue expansion, margin improvement, and evolving earnings.
Go toTop